Back to O& Oppenheimer & Co Inc

OTLKOTLK

7 quarters

Position history for O&Oppenheimer & Co Inc's holdings in Outlook Therapeutics, Inc.

Yes. Oppenheimer holds 16,500 shares of OTLK (Outlook Therapeutics), worth $9,463, as of its Q3 2026 13F filing. It increased the position by 2,500 shares (+17.9%) from Q2 2026. Oppenheimer has held OTLK since Q1 2026, across 3 quarterly 13F filings.

Current Value

$9,463

Current Shares

16,500

Total Value Change

-$7,007

Total Shares Change

+3,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
16,500
+17.9%
$9,4630.0%$0.57
20
2026-Q2
Decreased
14,000
-9.7%
$22,2600.0%$1.59
0
2026-Q1
New
15,500
—
$3,1900.0%$0.21
21
2025-Q4
Exited
0
-100.0%
$00.0%$1.58
0
2025-Q3
Decreased
13,000
-11.6%
$13,7800.0%$1.06
0
2025-Q2
Increased
14,700
+8.9%
$23,5200.0%$1.60
21
2025-Q1
New
13,500
—
$16,4700.0%$1.22
25

Optional analytics helps us improve. How it’s used